A Dimitrios Colevas - JoVE Visualize

Showing results (81-90 of 135) with videos related to

Pageof 14

Sort By:

Investigational New Drugs|July 18, 2016

A first-in-human phase I study to evaluate the MEK1/2 inhibitor, cobimetinib, administered daily in patients with advanced solid tumorsLee S Rosen, Patricia LoRusso, Wen Wee Ma, et al.

Theranostics|May 4, 2018

Safety of panitumumab-IRDye800CW and cetuximab-IRDye800CW for fluorescence-guided surgical navigation in head and neck cancersRebecca W Gao, Nutte Teraphongphom, Esther de Boer, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 20, 2025

First-in-Human Clinical Trial of a Small-Molecule EBNA1 Inhibitor, VK-2019, in Patients with Epstein-Barr-Positive Nasopharyngeal Cancer, with Pharmacokinetic and Pharmacodynamic StudiesA Dimitrios Colevas, Zahra Talebi, Elizabeth Winters, et al.

The Journal of Clinical Investigation|February 14, 2012

Stimulation of natural killer cells with a CD137-specific antibody enhances trastuzumab efficacy in xenotransplant models of breast cancerHolbrook E Kohrt, Roch Houot, Kipp Weiskopf, et al.

International Journal of Radiation Oncology, Biology, Physics|January 2, 2009

Long-term outcomes and toxicity of concurrent paclitaxel and radiotherapy for locally advanced head-and-neck cancerDeborah Citrin, John Mansueti, Anna Likhacheva, et al.

Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 31, 2021

Unambiguous advanced radiologic extranodal extension determined by MRI predicts worse outcomes in nasopharyngeal carcinoma: Potential improvement for future editions of N category systemsYanping Mao, Shunxin Wang, William Lydiatt, et al.

Nature Communications|November 8, 2019

Optical molecular imaging can differentiate metastatic from benign lymph nodes in head and neck cancerNaoki Nishio, Nynke S van den Berg, Stan van Keulen, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2005

Phase I and pharmacokinetic study of flavopiridol followed by 1-beta-D-arabinofuranosylcytosine and mitoxantrone in relapsed and refractory adult acute leukemiasJudith E Karp, Antonino Passaniti, Ivana Gojo, et al.

Journal of the National Comprehensive Cancer Network : JNCCN|November 11, 2015

NCCN Oncology Research Program's Investigator Steering Committee and NCCN Best Practices Committee Molecular Profiling SurveysRazelle Kurzrock, A Dimitrios Colevas, Anthony Olszanski, et al.

Cancer|December 11, 2012

Impact of positron emission tomography/computed tomography surveillance at 12 and 24 months for detecting head and neck cancer recurrenceAllen S Ho, Gabriel J Tsao, Frank W Chen, et al.

Pageof 14

Showing results (81-90 of 135) with videos related to

Sort By:

Pageof 14

Investigational New Drugs|July 18, 2016

A first-in-human phase I study to evaluate the MEK1/2 inhibitor, cobimetinib, administered daily in patients with advanced solid tumorsLee S Rosen, Patricia LoRusso, Wen Wee Ma, et al.

Theranostics|May 4, 2018

Safety of panitumumab-IRDye800CW and cetuximab-IRDye800CW for fluorescence-guided surgical navigation in head and neck cancersRebecca W Gao, Nutte Teraphongphom, Esther de Boer, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 20, 2025

First-in-Human Clinical Trial of a Small-Molecule EBNA1 Inhibitor, VK-2019, in Patients with Epstein-Barr-Positive Nasopharyngeal Cancer, with Pharmacokinetic and Pharmacodynamic StudiesA Dimitrios Colevas, Zahra Talebi, Elizabeth Winters, et al.

The Journal of Clinical Investigation|February 14, 2012

Stimulation of natural killer cells with a CD137-specific antibody enhances trastuzumab efficacy in xenotransplant models of breast cancerHolbrook E Kohrt, Roch Houot, Kipp Weiskopf, et al.

International Journal of Radiation Oncology, Biology, Physics|January 2, 2009

Long-term outcomes and toxicity of concurrent paclitaxel and radiotherapy for locally advanced head-and-neck cancerDeborah Citrin, John Mansueti, Anna Likhacheva, et al.

Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 31, 2021

Unambiguous advanced radiologic extranodal extension determined by MRI predicts worse outcomes in nasopharyngeal carcinoma: Potential improvement for future editions of N category systemsYanping Mao, Shunxin Wang, William Lydiatt, et al.

Nature Communications|November 8, 2019

Optical molecular imaging can differentiate metastatic from benign lymph nodes in head and neck cancerNaoki Nishio, Nynke S van den Berg, Stan van Keulen, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2005

Phase I and pharmacokinetic study of flavopiridol followed by 1-beta-D-arabinofuranosylcytosine and mitoxantrone in relapsed and refractory adult acute leukemiasJudith E Karp, Antonino Passaniti, Ivana Gojo, et al.

Journal of the National Comprehensive Cancer Network : JNCCN|November 11, 2015

NCCN Oncology Research Program's Investigator Steering Committee and NCCN Best Practices Committee Molecular Profiling SurveysRazelle Kurzrock, A Dimitrios Colevas, Anthony Olszanski, et al.

Cancer|December 11, 2012

Impact of positron emission tomography/computed tomography surveillance at 12 and 24 months for detecting head and neck cancer recurrenceAllen S Ho, Gabriel J Tsao, Frank W Chen, et al.

Pageof 14